MDedge Cardiocast Podcast
1) Top stories from the American Heart Association scientific sessions
ISCHEMIA trial hailed as practice changing The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves. DAPA-HF: Dapagliflozin’s HFrEF efficac...Show More
2) Vascepa gains event-reduction nod; diabetes ups ischemic risks
Vascepa approved for cardiovascular risk reduction The FDA’s decision on cutting events in high-risk patients was based primarily on the REDUCE-IT trial. ENGAGE AF-TIMI: Insulin linked to greater ris...Show More
3) Post-STEMI events less likely in women; bariatric surgery may lower stroke risk
Women have fewer cardiovascular events after non–ST-segment elevation ACS But they also remain undertreated with guideline-directed therapies. * * * Help us make this podcast better! Please take o...Show More
Post-STEMI events less likely in women; bariatric surgery may lower stroke risk
07:27 | Dec 13th, 2019
4) New trick for old drug; Vascepa cost effective for CV reduction
Icosapent ethyl cost effective in REDUCE-IT analysis Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo. * * * Help us make this pod...Show More
5) Card Talk: TAVR and glass ceilings
This week’s Cardiocast is devoted entirely to Card Talk with cardiologist brothers Jim and Jerry Dwyer. They welcome two structural interventionalists at the Structural Heart and Valve Center at Emory...Show More
6) ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special
In this special meeting edition of the Cardiocast, MDedge Cardiology editor Catherine Hackett is joined by MDedge reporters Mitchel L. Zoler, Bruce Jancin, and Richard Mark Kirkner. The MDedge cardio...Show More
7) Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF
ISCHEMIA trial hailed as practice changing The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves. * * * Help us make this podcast be...Show More
8) Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk
Getting high heightens stroke, arrhythmia risks Cannabis use or abuse among the young was associated with adverse cardiovascular consequences in two studies. * * * Help us make this podcast better!...Show More
9) How risk factors in childhood translate to CV outcomes in adulthood
Closing the missing link between childhood risk factors and adult cardiovascular outcomes Prescient childhood cohort studies launched in the 1970s are paying off. * * * Help us make this podcast bett...Show More
10) Driving while defibrillating; hypertension holds greater risk in black patients
Patients frequently drive too soon after ICD implantation Many patients didn’t recall ever receiving instruction about when to drive again. * * * Help us make this podcast better! Please take our shor...Show More
Driving while defibrillating; hypertension holds greater risk in black patients
07:51 | Nov 1st, 2019